grant

MATCHMAKERS

Organization UNIVERSITY OF WASHINGTONLocation SEATTLE, UNITED STATESPosted 1 May 2024Deadline 30 Apr 2027
NIHUS FederalResearch GrantFY20263-D structure3-dimensional structure3D structureAI basedAddressAffinityAlgorithmsAllelesAllelomorphsAntibodiesAntigen PresentationAntigen TargetingAntigen-Antibody ComplexAntigensBenchmarkingBest Practice AnalysisBindingBiochemicalCancer TreatmentCancersCodeCoding SystemComplexComputer ModelsComputerized ModelsComputing MethodologiesDataData SetDevelopmentDrugsEngineeringEventFDA approvedFaceFeedbackGenerationsGenetics-MutagenesisGoalsGrantHumanImmune ComplexImmune mediated therapyImmune responseImmune systemImmunityImmunologically Directed TherapyImmunologyImmunotherapyIncrease lifespanIndividualInstitutionInvestigatorsLibrariesLinkLytotoxicityMHC ReceptorMachine LearningMajor Histocompatibility Complex ReceptorMalignant MelanomaMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant TumorMalignant Tumor of the LungMalignant neoplasm of lungMeasuresMedicationMelanomaMethodsModelingModern ManMolecularMolecular InteractionMutagenesisMutagenesis Molecular BiologyOutputPeptide-MHCPeptide-Major Histocompatibility Protein ComplexPeptide/MHC ComplexPeptidesPharmaceutical PreparationsProbabilityProtein EngineeringProteinsPulmonary CancerPulmonary malignant NeoplasmReagentResearch PersonnelResearchersRestSightSiteSourceSpecificityStructureSystemT cell based immune therapyT cell based therapeuticsT cell based therapyT cell directed therapiesT cell immune therapyT cell immunotherapyT cell receptor based immunotherapyT cell receptor cellular immunotherapyT cell receptor engineered therapyT cell receptor immunotherapyT cell responseT cell targeted therapeuticsT cell therapyT cell treatmentT cell-based immunotherapyT cell-based treatmentT cellular immunotherapyT cellular therapyT lymphocyte based immunotherapyT lymphocyte based therapyT lymphocyte therapeuticT lymphocyte treatmentT-Cell Antigen Receptor SpecificityT-Cell Antigen ReceptorsT-Cell ReceptorT-Cell Receptor SpecificityT-Cell Receptor TherapyT-Cell Receptor TreatmentT-Cell Receptor based TherapyT-Cell Receptor based TreatmentT-CellsT-LymphocyteT-cell diversityT-cell receptor repertoireT-cell therapeuticsT-cell transfer therapyTCR T cell immunotherapyTCR T cell therapyTCR TherapyTCR based T cell immunotherapyTCR based TherapyTCR based immune therapyTCR based immunotherapyTCR based treatmentTCR immunotherapyTCR repertoireTestingTherapeuticToxic effectToxicitiesTrainingTumor AntigensTumor-Associated AntigenUncertaintyUniversitiesVisionWashingtonWorkadoptive T cell transferadoptive T lymphocyte transferadoptive T-cell therapyalgorithm developmentanti-cancer therapyartificial intelligence basedatomic databenchmarkboost longevitycancer antigenscancer therapycancer typecancer-directed therapycheck point blockadecheckpoint blockadecombinatorialcomputational methodologycomputational methodscomputational modelingcomputational modelscomputer based methodcomputer based modelscomputer methodscomputerized modelingcomputing methodcytotoxicitydata to traindataset to traindesigndesigningdevelopmentaldoubtdrug/agentelongating the lifespanenhance longevityextend life spanextend lifespanextend longevityfacesfacialfoster longevitygenetic protein engineeringhost responseimmune check point blockadeimmune checkpoint blockadeimmune system responseimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based therapiesimmune-based treatmentsimmuno therapyimmunogenimmunoresponseimprove lifespanimprove longevityimprovedinsightinterestintervention designlarge data setslarge datasetslarge scale datalarge scale data setslarge scale datasetslifespan extensionlung cancermachine based learningmalignancymethod developmentmonomermouse modelmurine modelneoplasm/cancernew drug classnext generationnovel drug classpMHCpersonalization of treatmentpersonalized medicinepersonalized therapypersonalized treatmentprolong lifespanprolong longevitypromote lifespanpromote longevityprotein complexprotein designquantumreceptor bindingreceptor boundresponsestructural biologysupport longevitytherapeutic T-cell platformtherapy designthree dimensional structurethymus derived lymphocytetraining datatraining datasetstreatment designtumortumor-specific antigenvisual function
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Abstract
Understanding how T cell receptors (TCRs) see tumor antigens presented by MHCs is necessary to fully

understand how the immune system recognizes tumor antigens, and to reap the full potential of antigen-specific

immunotherapy. To achieve this goal, a quantum leap forward is required in which the revolutionary advances in

machine learning are combined with a large volume of structure, function, data on matched TCR-pMHC pairs.

The development of accurate predictors of TCR-antigen recognition will be dependent on the creation and

integration sequencing-based datasets with high-throughput structural and functional insights. Our proposal,

submitted as a CRUK/NCI Grand Challenge team (MATCHMAKERS) will combine researchers with expertise in

immunology, methods development, structural biology, and computation to enable generalized prediction and

design of TCR recognition. This work will be spread across four Work Packages (WPs):

WP1: Large-scale generation of TCR-pMHC pairs from naturally occurring sources. We will build datasets of

naturally occurring TCR-pMHC pairs. Our team will use an array of approaches to collect these datasets, from

humans and from mouse models, and in the context of both cancer and immunity more generally.

WP2: Ultra-high throughput TCR-pMHC matching using molecular engineering. Efforts to create general models

will require a broader array of data than feasible to collect from natural TCR systems. We will use an array of

synthetic approaches developed by our team to comprehensively match TCRs with pMHCs to train

computational models.

WP3: Large-scale structural and biochemical analyses of TCR-pMHC interactions. A key to our team’s vision is

to match interaction datasets with high throughput structural and functional insights. A deep understanding of

how the TCR contacts with MHC helices control function and orientation will be essential for training and testing

computational models.

WP4 AI-based prediction and design of TCR-pMHC interactions. We will integrate our data to train next-

generation algorithms capable of generally predicting and designing TCR-pMHC interactions. These predictions

will proceed through a reiterative testing and feedback circuits for further model optimization.

Grant Number: 3OT2CA297288-01S2
NIH Institute/Center: NIH

Principal Investigator: DAVID BAKER

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →